难治性高血压患者易并存睡眠呼吸暂停

2016-08-10 许菁 中国循环杂志

研究发现,难治性高血压患者较一般高血压患者更易发生睡眠呼吸暂停综合征,由此这类患者的缺血事件与心衰风险也会增加。 本研究中的470 386例高血压患者中,有7.2%患者存在睡眠呼吸暂停综合征,9.6%患者为难治性高血压。 研究者发现,相比于非难治性高血压患者,难治性高血压患者的睡眠呼吸暂停综合征发生风险增加16%。 此外,肥胖(BMI≥30kg/m2)高血压患者的睡眠

研究发现,难治性高血压患者较一般高血压患者更易发生睡眠呼吸暂停综合征,由此这类患者的缺血事件与心衰风险也会增加。

 

本研究中的470 386例高血压患者中,有7.2%患者存在睡眠呼吸暂停综合征,9.6%患者为难治性高血压。

 

研究者发现,相比于非难治性高血压患者,难治性高血压患者的睡眠呼吸暂停综合征发生风险增加16%

 

此外,肥胖(BMI≥30kg/m2)高血压患者的睡眠呼吸暂停综合征发生风险增加2.6倍,男性患者的睡眠呼吸暂停风险增加1.2倍。

 

早有研究显示,睡眠呼吸暂停综合征与高血压之间存在双向相关性。阻塞性睡眠呼吸暂停综合征可通过交感神经兴奋增强、内皮功能损伤、肾素-血管紧张素-醛固酮系统紊乱等机制引起血压增高。

 

该研究还发现,合并睡眠呼吸暂停综合征的难治性高血压的患者发生缺血性心脏事件风险增加24%,充血性心衰发生风险增加43%

 

因此研究者表示,对于难治性高血压患者,应注意有无睡眠呼吸暂停综合征,并及时给予相应治疗。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1989017, encodeId=ff6d198901e66, content=<a href='/topic/show?id=246ee29858f' target=_blank style='color:#2F92EE;'>#睡眠呼吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72985, encryptionId=246ee29858f, topicName=睡眠呼吸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Thu Jul 13 05:33:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448163, encodeId=8d2e1448163df, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528324, encodeId=172e152832469, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596468, encodeId=cea715964685b, content=<a href='/topic/show?id=70e4396491a' target=_blank style='color:#2F92EE;'>#呼吸暂停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39649, encryptionId=70e4396491a, topicName=呼吸暂停)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2a518392360, createdName=119337463, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97317, encodeId=e2669e31755, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 10 17:00:00 CST 2016, time=2016-08-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1989017, encodeId=ff6d198901e66, content=<a href='/topic/show?id=246ee29858f' target=_blank style='color:#2F92EE;'>#睡眠呼吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72985, encryptionId=246ee29858f, topicName=睡眠呼吸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Thu Jul 13 05:33:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448163, encodeId=8d2e1448163df, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528324, encodeId=172e152832469, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596468, encodeId=cea715964685b, content=<a href='/topic/show?id=70e4396491a' target=_blank style='color:#2F92EE;'>#呼吸暂停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39649, encryptionId=70e4396491a, topicName=呼吸暂停)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2a518392360, createdName=119337463, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97317, encodeId=e2669e31755, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 10 17:00:00 CST 2016, time=2016-08-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1989017, encodeId=ff6d198901e66, content=<a href='/topic/show?id=246ee29858f' target=_blank style='color:#2F92EE;'>#睡眠呼吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72985, encryptionId=246ee29858f, topicName=睡眠呼吸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Thu Jul 13 05:33:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448163, encodeId=8d2e1448163df, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528324, encodeId=172e152832469, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596468, encodeId=cea715964685b, content=<a href='/topic/show?id=70e4396491a' target=_blank style='color:#2F92EE;'>#呼吸暂停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39649, encryptionId=70e4396491a, topicName=呼吸暂停)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2a518392360, createdName=119337463, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97317, encodeId=e2669e31755, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 10 17:00:00 CST 2016, time=2016-08-10, status=1, ipAttribution=)]
    2016-08-12 freve
  4. [GetPortalCommentsPageByObjectIdResponse(id=1989017, encodeId=ff6d198901e66, content=<a href='/topic/show?id=246ee29858f' target=_blank style='color:#2F92EE;'>#睡眠呼吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72985, encryptionId=246ee29858f, topicName=睡眠呼吸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Thu Jul 13 05:33:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448163, encodeId=8d2e1448163df, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528324, encodeId=172e152832469, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596468, encodeId=cea715964685b, content=<a href='/topic/show?id=70e4396491a' target=_blank style='color:#2F92EE;'>#呼吸暂停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39649, encryptionId=70e4396491a, topicName=呼吸暂停)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2a518392360, createdName=119337463, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97317, encodeId=e2669e31755, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 10 17:00:00 CST 2016, time=2016-08-10, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1989017, encodeId=ff6d198901e66, content=<a href='/topic/show?id=246ee29858f' target=_blank style='color:#2F92EE;'>#睡眠呼吸#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72985, encryptionId=246ee29858f, topicName=睡眠呼吸)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3138208, createdName=zhanfl, createdTime=Thu Jul 13 05:33:00 CST 2017, time=2017-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1448163, encodeId=8d2e1448163df, content=<a href='/topic/show?id=5a9c102681f2' target=_blank style='color:#2F92EE;'>#高血压患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102681, encryptionId=5a9c102681f2, topicName=高血压患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b4665409655, createdName=维他命, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528324, encodeId=172e152832469, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98601, encryptionId=74b798601a1, topicName=难治性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1ef11916292, createdName=freve, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1596468, encodeId=cea715964685b, content=<a href='/topic/show?id=70e4396491a' target=_blank style='color:#2F92EE;'>#呼吸暂停#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39649, encryptionId=70e4396491a, topicName=呼吸暂停)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e2a518392360, createdName=119337463, createdTime=Fri Aug 12 01:33:00 CST 2016, time=2016-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=97317, encodeId=e2669e31755, content=学习学习!, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Wed Aug 10 17:00:00 CST 2016, time=2016-08-10, status=1, ipAttribution=)]
    2016-08-10 1dd8c52fm63(暂无匿称)

    学习学习!

    0

相关资讯

Am J Hypertens:高血压前期和超重会诱发房颤?

背景和目的︰ 要防止中风,预防心房颤动 (AF) 和房颤的心电图早期检测是不可或缺的。然而,目前只有很少的一部分前瞻性研究验证了房颤危险因素,而血压(BP)和体质量指数 (BMI)仍未明确。我们研究了 BP 和BMI对AF 的风险。 方法: 共纳入了6906例患者(30-84岁),对其进行房颤的随访研究。确诊房颤:1.每2年一次例行健康检查,心电图诊断为房颤;2.健康检查/或医疗记录的随访期

2016高血压重要指南共识汇总

近期有关高血压研究领域的大量基础和临床研究,从不同方向、不同角度对高血压及其并发症的临床诊治进行了深入研究,为高血压的临床管理寻找最新方向。本文就近期高血压领域重要的指南共识进行回顾。小编盘点重要指南与共识,与大家分享。1,2016 钙拮抗剂/血管紧张素转换酶抑制剂单片复方制剂在高血压治疗中的应用中国专家建议目前,全球高血压患者的血压控制率仍不满意,我国高血压控制率和治疗控制率则更低,分别为9

通过尿线粒体DNA拷贝数识别高血压患者慢性肾损伤

升高的尿线粒体DNA拷贝数可作为高血压患者和肾功能损伤和不全的标志物,提示在人类高血压肾损害中存在线粒体损伤,为高血压肾损伤的诊断提供了新的指标。

Endocr Pract:顽固性高血压患者应筛查原发性醛固酮增多症

最近的研究数据表明,有高血压的人与非高血压人群相比,可能不会增加原发性醛固酮增多症风险;不过,顽固性高血压患者应筛查原发性醛固酮增多症。 来自纽约西奈山医学院糖尿病和骨疾病的Khadeen Christi Cheesman博士和同事对296名成年高血压患者的数据进行了评估。 根据血浆醛固酮浓度和醛固酮肾素比,选出了14名可能患有原发性醛固酮增多症的患者,初始测试率为4.7%。这些患者中

高血压治疗新思路:增加镁的摄入或有助于降压

镁是人体的基本元素,很多基础研究表明镁可能在血压调节中起着重要的作用,长期以来,研究人员也一直在探索镁在预防高血压中潜在价值,但是,目前临床研究结果存在争议,尚无定论。最近一项荟萃分析显示增加镁摄入明显降低收缩压和舒张压,但所纳入的研究在研究质量、样本数量和被纳入对象临床特点等方面均存在明显异质性,因此缺乏说服力。为了进一步明确并可靠地阐明补镁与预防高血压之间的关系,来自印第安纳大学的 Zhang

Circulation:伴无症状主动脉瓣狭窄的高血压患者其更佳血压控制目标应该是多少?

关于伴有无症状主动脉瓣狭窄(AS)的高血压患者治疗的研究甚少。本研究使用来自辛伐他汀和依泽替米贝治疗主动脉瓣狭窄(SEAS)试验的数据来评估该类患者最佳的血压控制目标。 研究共分析了1767例无症状性AS和无明显的动脉粥样硬化性疾病的患者。研究结果为全因死亡率、心血管死亡、心力衰竭、脑卒中、心肌梗死(MI)和主动脉瓣置换术(AVR)。使用Cox模型分析作为连续测量BP的累计平均值,及随时间变